Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Urologic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Hematologic Diseases 1 Colorectal Neoplasms 1

Interventions

Brentuximab Vedotin 21 Cyclophosphamide 20 fludarabine 16 Rituximab 13 Lenalidomide 13 Dexamethasone 12 fludarabine phosphate 10 Melphalan 10 Busulfan 10 Mycophenolic Acid 9 pirtobrutinib 7 dacetuzumab 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 Doxorubicin 6 Azacitidine 6 ruxolitinib 5 Vincristine 5 Prednisone 5 Imatinib Mesylate 5 Bone Marrow Transplantation 5 ponatinib 4 pomalidomide 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 Bendamustine Hydrochloride 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Albumins × Clear all

NCT06095752 2025-10-02

Multiple Myeloma Prognostic Indices

Assiut University

Hematologic Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡